Curcumin shows excellent therapeutic effect on psoriasis in mouse model

Area of Science:

• Immunology
• Pharmacology
• Dermatology

Background:

• Curcumin, a natural compound, exhibits anti-inflammatory and antioxidant properties.
• Potassium channel Kv1.3 is implicated in T cell function and psoriasis pathogenesis.
• Kv1.3 channels are expressed in T cells, which play a crucial role in psoriasis.

Purpose of the Study:

• To investigate the effects of curcumin on inflammatory factor secretion in T cells.
• To evaluate curcumin's efficacy in a mouse model of psoriasis.
• To assess curcumin's safety profile compared to cyclosporine.

Main Methods:

• In vitro studies on T cells treated with curcumin.
• In vivo studies using a keratin 14-vascular endothelial growth factor transgenic mouse model of psoriasis.
• Assessment of inflammatory markers, T cell proliferation, psoriasis symptoms, and kidney histology.

Main Results:

• Curcumin significantly inhibited secretion of inflammatory factors (IL-17, IL-22, IFN-γ, IL-2, IL-8, TNF-α) and T cell proliferation in vitro.
• Oral curcumin administration improved psoriasis symptoms (ear redness, thickness, weight) and reduced serum inflammatory factors in mice.
• Curcumin demonstrated anti-inflammatory effects and a favorable safety profile, with no observed kidney side effects unlike cyclosporine.

Conclusions:

• Curcumin effectively suppresses T cell-mediated inflammation relevant to psoriasis.
• Curcumin shows significant therapeutic potential for treating psoriasis with high efficacy and safety.
• Curcumin represents a promising alternative to existing treatments like cyclosporine for psoriasis.